Freeline Therapeutics Holdings plc ADR buy Wedbush
Start price
04.10.23
/
50%
€3.21
Target price
04.10.24
€7.61
Performance (%)
0.00%
Price
09.02.24
€3.21
Summary
This prediction is currently active. The BUY prediction by Wedbush is currently unchanged from the start price. This prediction currently runs until 04.10.24. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Freeline Therapeutics Holdings plc ADR | - | - |
| iShares Core DAX® | -3.033% | -0.013% |
| iShares Nasdaq 100 | -3.554% | -2.546% |
| iShares Nikkei 225® | -3.938% | 2.183% |
| iShares S&P 500 | -1.517% | -0.882% |
Comments by Wedbush for this prediction
In the thread Freeline Therapeutics Holdings plc ADR diskutieren
Freeline Therapeutics Holdings plc (NASDAQ: FRLN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock, up previously from $5.00.
Ratings data for FRLN provided by MarketBeat